Bromide

Bromide

SCHEMBL9465223

Br.CCCCCCCCCCCCCCCN(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SIGMAR1 known ✓ Q99720 1/20 0.39
DNM1 Q05193 8/20 1.00
TSHR P16473 2/20 0.69
ALDH1A1 P00352 1/20 0.69
THRB P10828 1/20 0.50
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
S1PR2 O95136 1/20 0.41
S1PR1 P21453 1/20 0.41
S1PR3 Q99500 1/20 0.41
S1PR5 Q9H228 1/20 0.41
GBA1 P04062 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL3014917 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL129468 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL7761001 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL21253124 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL130779 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL21293895 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL21250203 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL21293896 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL21247774 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL238107 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110586110-A Supported catalyst for preparing morpholine from diethylene glycol and preparation method thereof 四川鸿鹏新材料有限公司 2019-12-20 CN claimed
CN-103698501-A Cyanide-free hemolytic agent SHENZHEN SONOSCAPE TECHNOLOGY 2014-04-02 CN claimed
CN-101120921-B Target preparation consisting of liposome and nucleic acid coating contrast agent UNIV PLA 2ND MILITARY MEDICAL 2011-01-19 CN claimed
CN-101120921-A Target preparation consisting of liposome and nucleic acid coating contrast agent UNIV PLA 2ND MILITARY MEDICAL (CN) 2008-02-13 CN claimed
CN-119931538-A Preparation method of perovskite quantum dot adhesive film with high stability 上海创曜辉应用材料技术有限公司 2025-05-06 CN disclosed
CN-108084314-B P (AAEM-St) coated heart-shaped nano palladium particle composite material 安徽理工大学 2021-03-30 CN disclosed
CN-111698982-A Hair treatment composition 株式会社资生堂 2020-09-22 CN disclosed
CN-110586110-A Supported catalyst for preparing morpholine from diethylene glycol and preparation method thereof 四川鸿鹏新材料有限公司 2019-12-20 CN disclosed
WO-2019155968-A1 HAIR TREATMENT COMPOSITION 株式会社資生堂 2019-08-15 WO disclosed
US-10259851-B2 Protein extraction methods AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2019-04-16 US disclosed
CN-107430213-A Hydrophilic optical feature monofilm and its layered product 三井化学株式会社 2017-12-01 CN disclosed
CN-107250226-A Acrylic resin modified solidfied material and its layered product and their manufacture method 三井化学株式会社 2017-10-13 CN disclosed
CN-101514983-A Reagent for determining serum total carnitine SHANGHAI AILEX TECHNOLOGY CO L (CN) 2009-08-26 CN disclosed
CN-101514984-A Reagent for determining serum free carnitine SHANGHAI AILEX TECHNOLOGY CO L (CN) 2009-08-26 CN disclosed
CN-101120921-A Target preparation consisting of liposome and nucleic acid coating contrast agent UNIV PLA 2ND MILITARY MEDICAL (CN) 2008-02-13 CN disclosed
CN-1674912-A method for treating male erectile dysfunction NEXMED HOLDINGS INC (US) 2005-09-28 CN disclosed
CN-1665485-A Compositions and methods for amelioration of human female sexual dysfunction NEXMED HOLDINGS INC (US) 2005-09-07 CN disclosed
CN-1610559-A Prostaglandin composition for the treatment of erectile dysfunction NEXMED HOLDINGS INC (US) 2005-04-27 CN disclosed
CN-1081765-A Be used to measure the immunization method of haemoglobin dervative BOEHR INGER MANNHEIM GMBH (DE) 1994-02-09 CN disclosed
US-5250437-A Solution containing mixture of quaternary ammonium salts and oxidizing agent TOA MEDICAL ELECTRONICS CO., LTD. (JP) 1993-10-05 US disclosed